James Hu • USC Profiles (original) (raw)

  1. Physician Leadership and Burnout: The Need for Agency; a Qualitative Study of an Academic Institution. J Healthc Leadersh. 2024; 16:121-130. Hu JS, Pangaro LN, Gloria Andrada BM, Ceasar RC, Phillips JL. PMID: 38449510; PMCID: PMC10914963.
    View in: PubMed Mentions: 4
  2. Atezolizumab for Advanced Alveolar Soft Part Sarcoma. N Engl J Med. 2023 09 07; 389(10):911-921. Chen AP, Sharon E, O'Sullivan-Coyne G, Moore N, Foster JC, Hu JS, Van Tine BA, Conley AP, Read WL, Riedel RF, Burgess MA, Glod J, Davis EJ, Merriam P, Naqash AR, Fino KK, Miller BL, Wilsker DF, Begum A, Ferry-Galow KV, Deshpande HA, Schwartz GK, Ladle BH, Okuno SH, Beck JC, Chen JL, Takebe N, Fogli LK, Rosenberger CL, Parchment RE, Doroshow JH. PMID: 37672694; PMCID: PMC10729808.
    View in: PubMed Mentions: 64 Fields:
    Translation:HumansCTClinical Trials
  3. Physician Burnout-Evidence That Leadership Behaviors Make a Difference: A Cross-Sectional Survey of an Academic Medical Center. Mil Med. 2023 07 22; 188(7-8):e1580-e1587. Hu JS, Phillips J, Wee CP, Pangaro LN. PMID: 36260483.
    View in: PubMed Mentions: 4 Fields:
    Translation:Humans
  4. Tumor lysis syndrome following ifosfamide monotherapy in metastatic osteosarcoma: a case report and review of the literature. J Med Case Rep. 2022 Jun 28; 16(1):252. Luminais SN, Chen XT, Roman D, Ma B, Christ AB, Hu JS. PMID: 35761364; PMCID: PMC9238137.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  5. Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Cancer. 2021 03 01; 127(5):729-738. Tseng WW, Barretta F, Conti L, Grignani G, Tolomeo F, Albertsmeier M, Angele MK, Rutkowski P, Skoczylas J, De Paoli A, Navarria F, Raut CP, Fairweather M, Farma JM, Nessim C, Goel N, Grignol VP, Ford SJ, Cardona K, Subhawong T, Tattersall HL, Lee RM, Hu JS, von Mehren M, Sanfilippo R, Gronchi A. PMID: 33206381.
    View in: PubMed Mentions: 22 Fields:
    Translation:Humans
  6. Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue Sarcoma. Mol Cancer Ther. 2021 01; 20(1):132-141. Martín-Broto J, Pousa AL, Brohl AS, Van Tine BA, Powers B, Stacchiotti S, Blay JY, Hu JS, Oakley GJ, Wang H, Szpurka AM, Levy DE, Mo G, Ceccarelli M, Jones RL. PMID: 33177152.
    View in: PubMed Mentions: 10 Fields:
    Translation:HumansCellsCTClinical Trials
  7. Predictors of readmission after craniotomy for meningioma resection: a nationwide readmission database analysis. Acta Neurochir (Wien). 2020 11; 162(11):2637-2646. Lin M, Min E, Orloff EA, Ding L, Youssef KSR, Hu JS, Giannotta SL, Mack WJ, Attenello FJ. PMID: 32779026.
    View in: PubMed Mentions: 6 Fields:
    Translation:Humans
  8. Staging systems and nomograms in soft tissue sarcoma: outcome prediction by categorization or personalization? Chin Clin Oncol. 2019 Oct; 8(S1):S12. Tseng WW, Pasquali S, Hu JS, Menendez LR, Gronchi A. PMID: 30943728.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  9. Talimogene laherparepvec in combination with pembrolizumab leads to a complete response in a patient with refractory Merkel cell carcinoma. JAAD Case Rep. 2018 Nov; 4(10):1004-1006. Lara KM, In GK, Matcuk GR, Mehta A, Hu JS. PMID: 30450405; PMCID: PMC6226586.
    View in: PubMed Mentions: 9
  10. Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer. Cancer. 2017 Dec 01; 123(23):4566-4573. Dorff TB, Longmate JA, Pal SK, Stadler WM, Fishman MN, Vaishampayan UN, Rao A, Pinksi JK, Hu JS, Quinn DI, Lara PN. PMID: 28832978; PMCID: PMC5726867.
    View in: PubMed Mentions: 23 Fields:
    Translation:Humans
  11. Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations. Ther Adv Med Oncol. 2017 Aug; 9(8):533-550. In GK, Hu JS, Tseng WW. PMID: 28794805; PMCID: PMC5524246.
    View in: PubMed Mentions: 50
  12. Contemporary Management of Retroperitoneal Soft Tissue Sarcomas. Curr Oncol Rep. 2015 Aug; 17(8):39. Olimpiadi Y, Song S, Hu JS, Matcuk GR, Chopra S, Eisenberg BL, Sener SF, Tseng WW. PMID: 26092408.
    View in: PubMed Mentions: 12 Fields:
    Translation:Humans
  13. Contrast-Enhanced Sonography for Monitoring Neoadjuvant Chemotherapy in Soft Tissue Sarcomas. J Ultrasound Med. 2015 Aug; 34(8):1489-99. Gulati M, Hu JS, Desai B, Hwang DH, Grant EG, Duddalwar VA. PMID: 26206837.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  14. Salvage chemotherapy for refractory germ cell tumors. Oncology (Williston Park). 2014 Jun; 28(6):498-500. Dorff TB, Hu JS, Quinn DI. PMID: 25134324.
    View in: PubMed Mentions: Fields:
    Translation:Humans

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs